ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2205

Longitudinal Evaluation of the Performance of Different Classification Criteria in Patients with Primary Sjögren’s Syndrome

Martina Plešivčnik Novljan1, ŽIga Rotar2, Aleš Ambrožič1, Gaj Vidmar3 and Matija Tomšič1, 1Department of Rheumatology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia, 2Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 3University Rehabilitation Institute, 1000 Ljubljana, Slovenia

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and classification criteria

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome - Clinical

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Over the past 3 decades, 10 different classification criteria for Sjögren’s syndrome (SS) had been proposed. In 2001 and 2002 222 consecutive patients suspected of having primary SS (pSS) were each evaluated for pSS using the Copenhagen (COP), Californian (CA), European (EU) and American-European consensus group (AECG) criteria. 90 patients could be classified as pSS by at least one of the criteria.(1) The purpose of our current study was to prospectively compare the longitudinal performance of different classification criteria by reassessing the diagnosis in 2009 in the group of patients classified as pSS in 2001 and 2002.

Methods:

Eligible patients were invited for reassessment. In each patient we repeated diagnostic tests as required by any of the respective classification criteria. Additionally, we used the new ACR criteria (ocular stain score ≥3 was replaced by Rose Bengal score ≥ 3 following the Bijsterveld’s method) to classify the patients on the data from the initial cohort and at reassessment.(2) 

Results:

In 2009 63/90 (70%) of patients from the initial cohort consented to participate. The flow of the patients is summarized in Figure 1.

During the 7.5-year follow up period we observed a transition from pSS to secondary SS (sSS) in 9/63 (14%) patients on average after 4.0±0.9 years. While cases of transition from pSS to sSS were observed for all criteria used to make the initial diagnosis of pSS, it was significantly more common if the diagnosis of pSS was initially made using AECG (17%, p=0.008), or ACR (17%, p= 0.016) criteria.

In the 34 patients who underwent a full diagnostic reassessment the diagnosis retention rate was statistically significant for the CA, AECG, COP and ACR criteria, but not for the EU criteria (Table 1). At reassessment 3/32 (9%), and 2/26 (8%) of patients initially diagnosed as pSS using the EU, and COP criteria, respectively could not be classified as pSS by any of the criteria.

Although the difference between classification using the AECG, and new ACR criteria almost reached statistical significance for the initial 90 patients (p=0.063), the difference was lost at reassessment (p=1.000). 

Conclusion:

The longitudinal diagnosis retention rate is highest for the Californian and AECG criteria and lowest for the European criteria. Regardless of the classification criteria we observed that with time some patients develop sSS. When using classification criteria without mandatory positivity in immunoserology or histology there is a caveat of misclassification of patients as pSS.

Figure 1

Table 1

 

Meeting the criteria for pSS

Patients (100%)

Copenhagen

Californian

European

AECG 2002

ACR 2012

All the 34 pts.

before 7.5 years

26/34(76%)

12/34(35%)

32/34(94%)

24/34(71%)

22/34 (65%)

pSS not confirmed

after 7.5 years

2/26 (8%)

0/12 (0%)

3/32 (9%)

0/24 (0%)

0/22 (0%)

pSS confirmed anew

after 7.5 years

2/26 (8%)

1/12 (8%)

2/32 (6%)

1/24 (4%)

2/22 (9%)

All the 34 pts.

at follow-up

26/34 (76%)

13/34 (38%)

31/34 (91%)

25/34 (74%)

24/34 (71%)

 

Agreement between initial assessment and reassessment

Cohen’s Kappa

(95% confidence interval;

significance)

κ=0.673

(0.377, 0.969;

p=0.001)

κ=0.937

(0.815, 1.000;

p<0.001)

κ=–0.076

(–0.148, –0.004;

p=1.000)

κ=0.927

(0.787, 1.000;

p<0.001)

κ=0.866

(0.688, 1.000;

p<0.001)

References

1. Novljan MP, et al. Scand J Rheumatol 2006;35:463-8.

2. Shiboski SC, et al. Arthritis Care Res 2012;64:475-87.


Disclosure:

M. Plešivčnik Novljan,
None;

Rotar,
None;

A. Ambrožič,
None;

G. Vidmar,
None;

M. Tomšič,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/longitudinal-evaluation-of-the-performance-of-different-classification-criteria-in-patients-with-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology